Schedule IV (US federal law)
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:administeredBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:criteria |
Low potential for abuse relative to Schedule III
Accepted medical use in treatment in the United States Abuse may lead to limited physical or psychological dependence |
| gptkbp:dateEnacted |
1970
|
| gptkbp:example |
gptkb:Alprazolam
gptkb:Clonazepam gptkb:Diazepam gptkb:Lorazepam gptkb:Phenobarbital gptkb:Tramadol gptkb:Zolpidem gptkb:Modafinil gptkb:Carisoprodol |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule IV (US federal law)
|
| gptkbp:legalCitation |
21 U.S.C. § 812(b)(4)
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:regulates |
Prescription drugs
|
| gptkbp:bfsParent |
gptkb:Schedule_I_(US_federal_law)
|
| gptkbp:bfsLayer |
7
|